Position Statement: CSACI position statement - epinephrine auto-injectors and children < 15 kg
Position Statement: CSACI position statement - epinephrine auto-injectors and children < 15 kg
Visit VisitThis position statement addresses a number of questions regarding epinephrine administration/prescribing suggestions for the infant under 15kg who is at risk for anaphylaxis, including: What are possible consequences of administering a larger than recommended dose of epinephrine? Are there other ways to prescribe the recommended dose of epinephrine? What are the consequences of not administering epinephrine? What does the Canadian Society for Allergy and Clinical Immunology suggest for the infant less than 15kg?
